Volume 89, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



The Military Health System (MHS), with 9.7 million beneficiaries, represents an enormous pool of potential travelers requiring malaria prevention measures. A systematic search of the MHS electronic pharmacy record was performed for prescriptions of atovaquone-proguanil (AP), chloroquine (CQ), doxycycline (DC), mefloquine (MQ), primaquine (PQ) to adult patients from 2007 through 2011. Over 1,000,000 were identified, including 161,341 primary prophylaxis prescriptions originating from civilian facilities. Military facility prescription volume rose from 50,128 (PQ < 1%, AP 4%, CQ 6%, DC 53%, MQ 36%) in 2007 to 166,649 (PQ < 1%, AP 3%, CQ < 1%, DC 94%, MQ 2%) in 2011. Mefloquine use diminished in all clinics over time. The majority of military facility prescriptions originated from primary care clinics (83%); primary care clinics predominantly and increasingly prescribed DC, whereas specialty travel clinics predominantly and increasingly prescribed AP. Prescribing patterns in the MHS varied by time, practice setting, beneficiary status, and provider specialty. These changes, including among non-active duty military patients, are temporally associated with policy changes intended for the active duty force.


Article metrics loading...

Loading full text...

Full text loading...



  1. World Health Organization, 2011. World Malaria Report. Available at: http://www.who.int/mediacentre/news/releases/2011/malaria_report_20111213/en/. Accessed January 24, 2012.
  2. Centers for Disease Control and Prevention, 2012. Malaria Facts. Available at: http://www.cdc.gov/malaria/about/facts.html. Accessed January 24, 2012.
  3. Ciminera P, Brundage J, , 2007. Malaria in U.S. military forces: a description of deployment exposures from 2003 through 2005. Am J Trop Med Hyg 76: 275279.
  4. U.S. Medicine, 2011. The Military Health System in 2011. Available at: http://www.usmedicine.com/outlook/the-military-health-system-in-2011.html. Accessed January 24, 2012.
  5. Leggat PA, Heydon JL, , 2002. Trends in antimalarial drugs prescribed in New Zealand 1993 to 1998. J Travel Med 9: 156159.[Crossref]
  6. Leggat PA, Durrheim DN, Blumberg L, , 2002. Trends in malaria chemoprophylaxis prescription in South Africa 1994 to 2000. J Travel Med 9: 318321.[Crossref]
  7. Leggat PA, , 2012. Trends in antimalarial prescriptions in Australia, 2005 to 2009. J Travel Med 19: 357360.[Crossref]
  8. LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J, Connor BA, Goad JA, Oladele A, Alvarez S, Stauffer W, Walker P, Kozarsky P, Franco-Paredes C, Dismukes R, Rosen J, Hynes NA, Jacquerioz F, McLellan S, Hale D, Sofarelli T, Schoenfeld D, Marano N, Brunette G, Jentes ES, Yanni E, Sotir MJ, Ryan ET, , 2012. Global TravEpiNet: a national consortium of clinics providing care to international travelers—analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk U.S. international travelers, 2009–2011. Clin Infect Dis 54: 455462.[Crossref]
  9. Hickey PW, Gardner R, Coldren RL, , 2011. U.S. military force health protection policies may impact pediatric malaria prophylaxis prescribing patterns. Am J Trop Med Hyg 85 (Suppl): 390.
  10. U.S. Food and Drug Administration MedWatch Safety Information, 2003. Lariam (mefloquine hydrochloride). Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153319.htm. Accessed January 4, 2012.
  11. Office of the Assistant Secretary of Defense for Health Affairs (Force Health Protection and Readiness), 2002. Memorandum: Antimalarials and Current Practice in the Military. Available at: http://www.pdhealth.mil/malaria.asp. Accessed July 9, 2012.
  12. Armed Forces Epidemiological Board, 2003. Memorandum: Antimalarials and Current Practice in the Military 2003–13. Available at: http://www.pdhealth.mil/malaria.asp. Accessed July 9, 2012.
  13. Armed Forces Epidemiological Board, 2004. Memorandum: Armed Forces Epidemiological Board (AFEB) Select Subcommittee to Develop Mefloquine Study Options. Available at: http://www.pdhealth.mil/AFEBMemorandum.pdf. Accessed July 9, 2012.
  14. Office of the Assistant Secretary of Defense for Health Affairs, 2009. Memorandum: Policy Memorandum on the Use of Mefloquine (Lariam) in Malaria Prophylaxis. Available at: http://www.pdhealth.mil/malaria.asp. Accessed July 9, 2012.
  15. Centers for Disease Control and Prevention, 2012. Malaria. 2012 Yellow Book. Available at: http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/malaria.htm#1975. Accessed January 4, 2012.
  16. Centers for Disease Control and Prevention, 2012. Yellow fever and malaria information, by country. 2012 Yellow Book. Available at: http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/yellow-fever-and-malaria-information-by-country.htm. Accessed January 27, 2012.
  17. U.S. Department of Commerce, 2012. Office of Travel and Tourism Industries. U.S. International Air Passenger Statistics Report. Available at: http://tinet.ita.doc.gov/research/monthly/departures/index.html. Accessed November 4, 2012.
  18. Lalani T, Fraser J, Lederman E, Tribble DR, Maguire JD, , 2011. TRAVMIL: travel-related infectious disease risk assessment, outcomes and prevention strategies among Department of Defense beneficiaries. Am J Trop Med Hyg 85 (Suppl): 87.

Data & Media loading...

  • Received : 09 Jan 2013
  • Accepted : 10 Apr 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error